Annual Shareholders Equity
$1.03 B
+$571.35 M+123.28%
December 31, 2024
Summary
- As of March 15, 2025, RXRX annual stockholders equity is $1.03 billion, with the most recent change of +$571.35 million (+123.28%) on December 31, 2024.
- During the last 3 years, RXRX annual shareholders equity has risen by +$491.84 million (+90.59%).
- RXRX annual shareholders equity is now at all-time high.
Performance
RXRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.03 B
+$510.22 M+97.27%
December 31, 2024
Summary
- As of March 15, 2025, RXRX quarterly stockholders equity is $1.03 billion, with the most recent change of +$510.22 million (+97.27%) on December 31, 2024.
- Over the past year, RXRX quarterly shareholders equity has increased by +$510.22 million (+97.27%).
- RXRX quarterly shareholders equity is now at all-time high.
Performance
RXRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RXRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +123.3% | +97.3% |
| 3 y3 years | +90.6% | +97.3% |
| 5 y5 years | +932.7% | +97.3% |
RXRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.3% | at high | +166.7% |
| 5 y | 5-year | at high | +601.6% | at high | +544.0% |
| alltime | all time | at high | +601.6% | at high | +544.0% |
Recursion Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.03 B(+123.3%) | $1.03 B(+97.3%) |
| Sep 2024 | - | $524.56 M(-10.2%) |
| Jun 2024 | - | $584.45 M(+45.7%) |
| Mar 2024 | - | $401.15 M(-13.4%) |
| Dec 2023 | $463.44 M(-4.6%) | $463.44 M(+5.8%) |
| Sep 2023 | - | $437.97 M(-6.6%) |
| Jun 2023 | - | $468.96 M(+9.0%) |
| Mar 2023 | - | $430.18 M(-11.5%) |
| Dec 2022 | $485.81 M | $485.81 M(+25.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $388.03 M(-11.3%) |
| Jun 2022 | - | $437.58 M(-11.3%) |
| Mar 2022 | - | $493.57 M(-9.1%) |
| Dec 2021 | $542.94 M(-363.2%) | $542.94 M(-9.4%) |
| Sep 2021 | - | $599.03 M(-6.8%) |
| Jun 2021 | - | $642.71 M(-375.8%) |
| Mar 2021 | - | -$233.03 M(+13.0%) |
| Dec 2020 | -$206.29 M(+66.0%) | - |
| Dec 2020 | - | -$206.29 M |
| Dec 2019 | -$124.27 M | - |
FAQ
- What is Recursion Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual shareholders equity year-on-year change?
- What is Recursion Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Recursion Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of RXRX is $1.03 B
What is the all time high annual shareholders equity for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual stockholders equity is $1.03 B
What is Recursion Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, RXRX annual stockholders equity has changed by +$571.35 M (+123.28%)
What is Recursion Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of RXRX is $1.03 B
What is the all time high quarterly shareholders equity for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly stockholders equity is $1.03 B
What is Recursion Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, RXRX quarterly stockholders equity has changed by +$510.22 M (+97.27%)